prof. Yolande Lievens
Show
Sort by
-
CHART in lung cancer: economic evaluation and incentives for implementation
-
Economic consequence of local control with radiotherapy: cost analyses of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer
-
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884)
-
Overview of national guidelines for infrastructure and staffing of radiotherapy: ESTRO-QUARTS: work package 1
-
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience
-
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
-
Activity-based costing: a practical model for cost calculation in radiotherapy
-
Dose-intensified accelerated vindesine-ifosfamide-cisplatin (VIP) chemotherapy followed by high-dose accelerated hyperfractionated radiotherapy in patients with pathologically proven stage IIIB non-small cell lung cancer: a feasibility study
-
Internal mammary and medial supraclavicular lymph node irradiation: the thin line between advantages and side effects
-
Does sucralfate reduce early side effects of pelvic radiation?: a double-blind randomized trial